Search Results - "HENEGHAN, M"

Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer by Martin, S. T., Heneghan, H. M., Winter, D. C.

“…Background: Following neoadjuvant chemoradiotherapy (CRT) and interval proctectomy, 15–20 per cent of patients are found to have a pathological complete…”
Get full text

Determinants of long‐term outcome in severe alcoholic hepatitis by Potts, J. R., Goubet, S., Heneghan, M. A., Verma, S.

“…Summary Background Although short‐term outcome in severe alcoholic hepatitis (SAH) is well described, its long‐term course remains uncharacterised. Aim To…”
Get full text

Systematic review of outcomes after intersphincteric resection for low rectal cancer by Martin, S. T., Heneghan, H. M., Winter, D. C.

“…Background: For a select group of patients proctectomy with intersphincteric resection (ISR) for low rectal cancer may be a viable alternative to…”
Get full text

Bariatric surgery and cardiovascular outcomes: a systematic review by Vest, Amanda R, Heneghan, Helen M, Agarwal, Shikhar, Schauer, Philip R, Young, James B

“…To quantify the impact of bariatric surgery on cardiovascular (CV) risk factors, and on cardiac structure and function. Three major databases (PubMed, Medline…”
Get more information

Pregnancy outcomes in women with Budd–Chiari syndrome or portal vein thrombosis: a multicentre retrospective cohort study by Chung, YY, Heneghan, MA

“…Linked article: This is a mini commentary on HMG Wiegers et al., pp. 608–617 in this issue. To view this article visit https://doi.org/10.1111/1471-0528.16915…”
Get full text

Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer by HENEGHAN, Helen M, MILLER, Nicola, LOWERY, Aoife J, SWEENEY, Karl J, NEWELL, John, KERIN, Michael J

“…The development of clinically validated biomarkers for cancer has remained an insurmountable task despite other advances in the field of cancer molecular…”
Get full text

Differential miRNA Expression in Omental Adipose Tissue and in the Circulation of Obese Patients Identifies Novel Metabolic Biomarkers by Heneghan, H. M, Miller, N, McAnena, O. J, O'Brien, T, Kerin, M. J

“…Candidate miRNAs are altered in omental fat and circulation of obese individuals and highlight the potential of miRNAs as novel metabolic biomarkers…”
Get full text

Prospective Study of Malabsorption and Malnutrition After Esophageal and Gastric Cancer Surgery by Heneghan, Helen M, Zaborowski, Alexandra, Fanning, Michelle, McHugh, Aisling, Doyle, Suzanne, Moore, Jenny, Ravi, Nayarasamy, Reynolds, John V

“…To study malabsorption and malnutrition after curative resection of esophageal and gastric cancer. Prospective cohort study. Improved cure rates for esophageal…”
Get full text

Systemic miRNA‐195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease by Heneghan, Helen M., Miller, Nicola, Kelly, Ronan, Newell, John, Kerin, Michael J.

“…Learning Objectives After completing this course, the reader will be able to: Describe the site‐specific dysregulation of some miRNAs and explain their…”
Get full text

Can CT-PET and Endoscopic Assessment Post-Neoadjuvant Chemoradiotherapy Predict Residual Disease in Esophageal Cancer? by Heneghan, Helen M, Donohoe, Claire, Elliot, Jessie, Ahmed, Zuhair, Malik, Vinod, Ravi, Narayamasamy, Reynolds, John V

“…OBJECTIVE:The aim of this study is to assess CT-PET and endoscopic assessment postneoadjuvant chemoradiotherapy (nCRT) in predicting complete pathologic…”
Get full text

Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long‐term outcome and survival by AL‐CHALABI, T., PORTMANN, B. C., BERNAL, W., MCFARLANE, I. G., HENEGHAN, M. A.

“…Summary Background  Primary sclerosing cholangitis/autoimmune hepatitis (PSC/AIH) and primary biliary cirrhosis/AIH (PBC/AIH) overlap syndromes are poorly…”
Get full text

Expert clinical management of autoimmune hepatitis in the real world by Liberal, R., Boer, Y. S., Andrade, R. J., Bouma, G., Dalekos, G. N., Floreani, A., Gleeson, D., Hirschfield, G. M., Invernizzi, P., Lenzi, M., Lohse, A. W., Macedo, G., Milkiewicz, P., Terziroli, B., Hoek, B., Vierling, J. M., Heneghan, M. A., Pares, A., Montano‐Loza, A. J., Granito, A., Kremer, A. E., Floreani, A., Lohse, A. W., Hoek, B., Terziroli, B., Schramm, C., Lammert, C., Cancado, E. L. R., Bjornsson, E., Lammert, F., Dalekos, G. N., Bouma, G., Hirschflield, G. M., Macedo, G., Hofer, H., Mackay, I., Neuberger, J., Vierling, J. M., Drenth, J.P.H., Nieuwkerk, C.M.J., Muratori, L., Lenzi, M., Swain, M., Heneghan, M., Zeniya, M., Chazouilleres, O., Gines, P., Invernizzi, P., Milkiewicz, P., Andrade, R. J., Chapman, R., Berg, T., Buuren, H., Ma, X.

“…Summary Background High‐quality data on the management of autoimmune hepatitis (AIH) are scarce. Despite published guidelines, management of AIH is still…”
Get full text

Role of microRNAs in obesity and the metabolic syndrome by Heneghan, H.M, Miller, N, Kerin, M.J

“…Obesity and the metabolic syndrome are major public health concerns, and present a formidable therapeutic challenge. Many patients remain recalcitrant to…”
Get full text

Meta‐analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy by Fleming, C. A., Heneghan, H. M., O'Brien, D., McCartan, D. P., McDermott, E. W., Prichard, R. S.

“…Background Optimal management of the endometrium in patients with oestrogen receptor‐positive breast cancer taking extended tamoxifen therapy (for 10 years)…”
Get full text

Sun exposure and risk of melanoma by Oliveria, S A, Saraiya, M, Geller, A C, Heneghan, M K, Jorgensen, C

“…Background: As skin cancer education programmes directed to children and adolescents continue to expand, an epidemiological basis for these programmes is…”
Get full text

Review article: the modern management of autoimmune hepatitis by YEOMAN, A. D., LONGHI, M. S., HENEGHAN, M. A.

“…Aliment Pharmacol Ther 31, 771–787 Summary Background  The management of autoimmune hepatitis (AIH) continues to be refined. However, several issues remain…”
Get full text

Surgical Management of Obesity and the Relationship to Cardiovascular Disease by VEST, Amanda R, HENEGHAN, Helen M, SCHAUER, Philip R, YOUNG, James B

Get full text

Effect of Bariatric Surgery on Cardiovascular Risk Profile by Heneghan, Helen M., MD, Meron-Eldar, Shai, MD, Brethauer, Stacy A., MD, Schauer, Philip R., MD, Young, James B., MD

“…Obesity is associated with increased risk for cardiovascular (CV) disease (CVD) and CV mortality. Bariatric surgery has been shown to resolve or improve CVD…”
Get full text

The inter‐relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis by Dyson, J. K, Wilkinson, N., Jopson, L., Mells, G., Bathgate, A., Heneghan, M. A., Neuberger, J., Hirschfield, G. M., Ducker, S. J., Sandford, R., Alexander, G., Stocken, D., Jones, D. E. J.

“…Summary Background Age at presentation with primary biliary cholangitis (PBC) is associated with differential response to ursodeoxycholic acid (UDCA) therapy…”
Get full text

Influence of pouch and stoma size on weight loss after gastric bypass by Heneghan, Helen M., M.D, Yimcharoen, Panot, M.D, Brethauer, Stacy A., M.D, Kroh, Matthew, M.D, Chand, Bipan, M.D

“…Abstract Background Enlargement of the gastric pouch and/or gastrojejunostomy after Roux-en- Y gastric bypass (RYGB) is postulated to be the antecedent to…”
Get full text